However, we noticed that markers such as p21Cip1 and H3K9Me3 are less likely to be reliable indicators for TIS in breast cancer since their protein expression levels do not undergo significant changes after exposure to chemotherapy, while Lamin B1 undergoes significant reduction and potentially provides a better in vivo marker of TIS47. The gene discussed is CDKN1A; the disease is breast carcinoma.